Arbutus Biopharma
ABUS
ABUS
53 hedge funds and large institutions have $207M invested in Arbutus Biopharma in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 8 closing their positions.
Holders
53
Holders Change
+3
Holders Change %
+6%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
15
Reduced
15
Closed
8
Calls
$141K
Puts
$169K
Net Calls
-$28K
Net Calls Change
-$322K
Top Buyers
1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$1.39M |
2 |
SSA
2
Schonfeld Strategic Advisors
New York
|
$775K |
3 |
3
Morgan Stanley
New York
|
$2.61M |
4 |
RI
4
RTW Investments
New York
|
$32.7M |
5 |
5
UBS Group
Zurich,
Switzerland
|
$326K |